Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exposure to Novel Brominated and Organophosphate Flame Retardants and Associations With Type 2 Diabetes

NCT06239506 is registered in ClinicalTrials.gov with Xiaoling Guan as lead sponsor.

NCT NCT06239506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06239506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exposure to Novel Brominated and Organophosphate Flame Retardants and Associations With Type 2 Diabetes
Lead sponsor
Xiaoling Guan
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 30, 2024
Enrollment
340 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fasting plasma glucose, novel brominated flame retardants, organophosphate flame retardants, type 2 diabetes